These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 4787510)

  • 1. [Effects of treatment with neuraminidase on the immunogenicity of ATPC tumor cells].
    Iorio AM; Rivosecchi P; Santoni A; Fabiani L
    Boll Soc Ital Biol Sper; 1973 Mar; 49(9):462-6. PubMed ID: 4787510
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
    Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential effect of neuraminidase on the immunogenicity of viral associated and private antigens of mammary carcinomas.
    Simmons RL; Rios A
    J Immunol; 1973 Dec; 111(6):1820-5. PubMed ID: 4750868
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transplantability and immunogenicity in mice of lymphoma Nk/Ly cells modified by concanavalin A and neuraminidase].
    Bratus' GG; Darchuk GF
    Eksp Onkol; 1989; 11(3):35-8. PubMed ID: 2752940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunogenicity of L5178Y cells modified by different reagents].
    Gómez-Estrada H; López-de la Rosa LM; Becerril-Meza G; Arellano-Blanco J; Fernández-Quintero P
    Arch Invest Med (Mex); 1977; 8(2):113-22. PubMed ID: 410377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of neuraminidase in experimental immunotherapy of two murine pulmonary carcinomas.
    Alley CD; Snodgrass MJ
    Cancer Res; 1977 Jan; 37(1):95-101. PubMed ID: 830425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

  • 8. Micro-necrotic foci in regression of a murine calvarium transplantable tumor. 2. Enzymatic modification of the transformed calvarium cell immunological characteristics.
    Hakim AA
    Neoplasma; 1980; 27(4):449-58. PubMed ID: 7453860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
    Song CW; Levitt SH
    Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic proteins and synthetic polynucleotides as modifiers of immunogenicity of syngeneic tumor cells.
    Braun W; Plescia OJ; Raskova J; Webb D
    Isr J Med Sci; 1971 Jan; 7(1):72-82. PubMed ID: 4100526
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible immunological action of Vibrio cholerae neuraminidase (VCN) in tumor immunotherapy.
    Sedlacek HH; Johannsen R; Seiler FR
    Dev Biol Stand; 1977 Apr 13-15; 38():387-98. PubMed ID: 608528
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulatory effect of Vibrio cholerae neuraminidase on the antibody response to various antigens.
    Knop J; Sedlacek HH; Seiler FR
    Immunology; 1978 Feb; 34(2):181-7. PubMed ID: 342397
    [No Abstract]   [Full Text] [Related]  

  • 14. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
    Rios A; Simmons RL
    Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro evidence that Vibrio Cholerae neuraminidase increases antigenicity of sarcoma cells.
    Faraci RP; Ketcham AS
    Surg Forum; 1974; 25(0):99-101. PubMed ID: 4439267
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of leukemia L1210 cells after neuraminidase treatment.
    Bekesi JG; St Arneault G; Walter L; Holland JF
    J Natl Cancer Inst; 1972 Jul; 49(1):107-18. PubMed ID: 4338766
    [No Abstract]   [Full Text] [Related]  

  • 18. [The morphofunctional characteristics of lymphoma NK/LY cells treated with concanavalin A and Vibrio cholerae neuraminidase].
    Bratus' GG; Naumenko OI; Nastenko EP; Novichenko NL
    Tsitologiia; 1990; 32(1):67-73. PubMed ID: 2375060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response to ATPC+ascites tumour in mice rendered resistant by intravenous inoculation of liver cells.
    Pitzurra M; Marconi P
    Boll Ist Sieroter Milan; 1972; 51(5):393-404. PubMed ID: 4656954
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of Vibrio cholera neuraminidase on chemically induced carcinogenesis].
    Solov'ev VD; Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Gudkova RB
    Vestn Akad Med Nauk SSSR; 1974; (8):63-6. PubMed ID: 4471645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.